Get started
Author

Cathy Hewison

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study
2008 · Gerardo Priotto, Loretxu Pinoges, et al. · BMJ · 98
PDF
Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden
2006 · Maryline MB Bonnet, Loretxu LP Pinoges, et al. · AIDS · 92
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
2015 · Grania Brigden, Cathy Hewison, et al. · Infection and Drug Resistance · 67
PDF
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study
2020 · Molly F. Franke, Palwasha Khan, et al. · American Journal of Respiratory and Critical Care Medicine · 56
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
2017 · Jay Achar, Cathy Hewison, et al. · Emerging infectious diseases · 52
PDF
Six-Month Response to Delamanid Treatment in MDR TB Patients
2017 · Cathy Hewison, Gabriella Ferlazzo, et al. · Emerging infectious diseases · 42
PDF
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study
2018 · Mathieu Bastard, Elisabeth Sanchez-Padilla, et al. · PLoS ONE · 31
PDF
Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia
2017 · Maryline Bonnet, Kim Chamroeun San, et al. · Emerging infectious diseases · 29
PDF
Target product profiles: tests for tuberculosis treatment monitoring and optimization
2023 · Ankur Gupta-Wright, Saskia den Boon, et al. · Bulletin of the World Health Organization · 25
PDF
Field Evaluation of a Simple Fluorescence Method for Detection of Viable Mycobacterium tuberculosis in Sputum Specimens during Treatment Follow-Up
2012 · Birgit Schramm, Cathy Hewison, et al. · Journal of Clinical Microbiology · 21
Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis
2019 · Erika Mohr, Gabriella Ferlazzo, et al. · The Lancet Infectious Diseases · 17
PDF
Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe
2021 · Nara Melikyan, Helena Huerga, et al. · Open Forum Infectious Diseases · 10
Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?
2015 · Mathieu Bastard, Maryline Bonnet, et al. · American Journal of Respiratory and Critical Care Medicine · 10
Now is the time for shorter all-oral regimens for multidrug-resistant tuberculosis
2019 · Kwonjune J Seung, Cathy Hewison · The Lancet Global Health · 8
PDF
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
2022 · Carly A. Rodriguez, Sara Lodi, et al. · PLoS ONE · 6
PDF
Working in a war zone. The impact on humanitarian health workers.
2003 · Cathy Hewison · PubMed · 5
Middlebrook 7h11 Reduces Invalid Results and Turnaround Time of Phenotypic Drug-Susceptibility Testing of M. Tuberculosis
2022 · Praharshinie Rupasinghe, Jens Vereecken, et al. · International Journal of Mycobacteriology · 2
PDF
Leveraging nutritional rehabilitation and tuberculosis programmes to tackle tuberculosis and severe acute malnutrition in children
2025 · Bryan J Vonasek, Olivier Marcy, et al. · The Lancet Child & Adolescent Health · 1
Diagnostic Accuracy of the Novel FujiLAM Assay to Detect Tuberculosis in HIV-Positive Ambulatory Patients from Four African Countries
2022 · Helena Huerga, Mathieu Bastard, et al. · SSRN Electronic Journal · 1
Implementing computer‑aided detection for TB active case finding: A qualitative study of feasibility and acceptability in Tondo, Manila
2026 · Emelie Yonally Phillips, Ma. Danica Katrina P. Galvan, et al. · PLOS Global Public Health
PDF
Comparative Effectiveness of Three Linezolid Management Strategies for Peripheral Neuropathy During Multidrug- or Rifampicin-Resistant Tuberculosis Treatment: A Target Trial Emulation
2026 · Matthew Romo*, Malik Adenov, et al. · Epidemiology
Using causal frameworks to reduce bias in observational TB research: a comparison of model-building approaches
2026 · Lucia Barcellini, Sara Sauer, et al. · IJTLD OPEN
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort study
2025 · Matthew L. Romo, Allison LaHood, et al. · BMJ Open Respiratory Research
PDF
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 · N Lachenal, CCH Hewison, et al.
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 · N Lachenal, CCH Hewison, et al.
PDF
Works count: 35
Citation count: 573
H-index: 11
I10-index: 13
Year
Topic
Type